Long-acting injectable aripiprazole in pregnant women with schizophrenia: a case-series report

• Hauptverfasser: Blanca Fernández-Abascal (Verfasst von), Maria Recio-Barbero (Verfasst von), Margarita Sáenz-Herrero (Verfasst von), Rafael Segarra (Verfasst von)
• Format: Buch
• Veröffentlicht: SAGE Publishing, 2021-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Antipsychotic long-acting formulations (LAI-AP) have emerged as a new therapeutic choice to treat patients presenting a severe mental disorder. Despite that, to date, there is a lack of safety data and studies regarding the use of LAI-AP formulations in pregnant women. Here we present the first six-...